Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A urinary antiseptic combination used primarily for treating urinary tract infections (UTIs) and related symptoms. It contains four active ingredients that work together to provide antimicrobial and symptomatic relief effects. This combination contains methenamine (250mg), methylthioninium chloride (20mg), acriflavine (15mg), and Atropa belladonna L. extract (15mg). It's used in the treatment of recurrent cystitis and urinary tract infections. **Mechanism of Action:** * **Methenamine**: Decomposes in acidic urine to release formaldehyde, which has antimicrobial properties. * **Methylthioninium (Methylene blue)**: Acts as an oxidation-reduction agent with antiseptic properties. * **Acriflavine**: Provides additional antimicrobial activity. * **Atropa belladonna L.**: Contains anticholinergic compounds that help relieve urinary tract spasms and discomfort.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on methenamine + methylthioninium + acriflavine + atropa belladonna.